Dare Bioscience Inc (DARE)

0.301 -0.03 (-8.26%) USD  |  NASDAQ  |  May 02, 12:24
More

Dare Bioscience Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Upgrade now.
Date Value
June 29, 2023 16.22
June 28, 2023 16.14
June 27, 2023 16.31
June 26, 2023 16.32
June 23, 2023 16.58
June 22, 2023 16.49
June 21, 2023 16.66
June 20, 2023 16.75
June 16, 2023 16.49
June 15, 2023 16.66
June 14, 2023 16.69
June 13, 2023 16.84
June 12, 2023 17.01
June 09, 2023 17.01
June 08, 2023 17.10
June 07, 2023 17.17
June 06, 2023 17.01
June 05, 2023 17.35
June 02, 2023 17.70
June 01, 2023 17.53
May 31, 2023 17.53
May 30, 2023 17.53
May 26, 2023 17.01
May 25, 2023 17.06
May 24, 2023 17.25
Date Value
May 23, 2023 17.36
May 22, 2023 17.53
May 19, 2023 17.88
May 18, 2023 17.70
May 17, 2023 17.88
May 16, 2023 18.22
May 15, 2023 17.53
May 12, 2023 17.28
May 11, 2023 17.53
May 10, 2023 17.53
May 09, 2023 17.52
May 08, 2023 17.35
May 05, 2023 17.35
May 04, 2023 17.21
May 03, 2023 17.06
May 02, 2023 17.02
May 01, 2023 17.52
April 28, 2023 17.35
April 27, 2023 17.18
April 26, 2023 17.09
April 25, 2023 17.18
April 24, 2023 17.68
April 21, 2023 17.33
April 20, 2023 17.33
April 19, 2023 17.51

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

2.436
Minimum
Aug 07 2019
139.30
Maximum
Jul 14 2020
18.09
Average
7.634
Median
Mar 13 2023

Price to Book Value Benchmarks

Altimmune Inc 2.560
Verastem Inc 4.385
Oragenics Inc 3.043
Actinium Pharmaceuticals Inc 5.657
Orgenesis Inc --

Price to Book Value Related Metrics

Price 0.301
Earnings Yield -113.0%
Market Cap 30.28M